Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Factor VIII Activators

Common Factor VIII Activators include, but are not limited to Desmopressin CAS 16679-58-6, Vitamin K1 CAS 84-80-0, Tranexamic acid CAS 1197-18-8, Etamsylate CAS 2624-44-4 and Cholecalciferol CAS 67-97-0.

Factor VIII, also known as coagulation factor VIII, is a crucial protein in the blood coagulation cascade. It plays a pivotal role in hemostasis by participating in the formation of blood clots. Factor VIII circulates in the bloodstream in an inactive form, and upon activation, it interacts with other coagulation factors to initiate a series of enzymatic reactions that ultimately lead to the conversion of fibrinogen to fibrin, resulting in the formation of a stable blood clot. Factor VIII deficiency, often caused by genetic mutations, can lead to bleeding disorders, such as hemophilia A. Factor VIII Activators constitute a class of chemical compounds that could potentially enhance the activity or availability of factor VIII, impacting its role in the coagulation cascade.

The potential mechanism of action of Factor VIII Activators might involve targeting various steps in the activation or stabilization of factor VIII. Activators could potentially increase the activation of factor VIII from its inactive form to its active form, allowing it to efficiently participate in the coagulation process. Additionally, these activators might influence the interaction of factor VIII with other coagulation factors, such as factor IX and von Willebrand factor, to optimize the assembly of the tenase complex, which is essential for the conversion of prothrombin to thrombin. Since factor VIII is prone to degradation, activators might also impact its stability and half-life in the bloodstream, affecting its availability for coagulation processes. While the concept of Factor VIII Activators holds promise, more research is necessary to elucidate the specific molecular mechanisms underlying factor VIII activation and the potential ways in which these activators could modulate its function within the intricate coagulation cascade.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Desmopressin

16679-58-6sc-391126
1 mg
$135.00
(0)

Increases von Willebrand factor and factor VIII release. Used to treat bleeding disorders.

Vitamin K1

84-80-0sc-280189
sc-280189A
1 g
5 g
$79.00
$163.00
(0)

Essential for proper clotting factor synthesis, including factor VIII.

Tranexamic acid

1197-18-8sc-204921
sc-204921A
5 g
10 g
$28.00
$49.00
10
(1)

Antifibrinolytic agent, stabilizes clot formation. Used to treat bleeding disorders, including those involving factor VIII.

Etamsylate

2624-44-4sc-359616
10 mg
$175.00
1
(0)

May enhance platelet function and clotting, including factor VIII-related processes.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$70.00
$160.00
$290.00
2
(1)

Potential role in modulating coagulation, which could include factor VIII-related pathways.